Allogenic stem cells for Crohn's anal fistulas: Treating early improves the deep remission rate.

Nadia FathallahLaurent SiproudhisMélissa AkaffouMohamed Amine HaouariAmandine LandemaineElise PommaretLucas SpindlerCharlène Brochard Guillaume BouguenVincent de Parades

Published in: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland (2023)

Darvadstrocel injection resulted in a clinical response for two thirds of patients and deep remission for one third. A shorter duration of Crohn's disease was associated with deep remission.

Keyphrases

stem cells
end stage renal disease
disease activity
ejection fraction
ulcerative colitis
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
patient reported outcomes
mesenchymal stem cells
patient reported